Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

No Comments

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

No Comments

Yamanouchi files for approval of hypoglycemic agent

Oct. 15, 1997

No Comments

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

No Comments

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Oct. 15, 1997

No Comments

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

Oct. 14, 1997

No Comments

Heterocyclic compounds from Zeneca for hypercholesterolemia

Oct. 14, 1997

No Comments

Gonal-F approved for marketing in U.S.

Oct. 13, 1997

No Comments

Cambridge NeuroScience awarded sixteenth SBIR grant

Oct. 13, 1997

No Comments

Roussel Uclaf develops estrogenic compounds

Oct. 9, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Sensus reports early clinical results with B2036-PEG

Yamanouchi files for approval of hypoglycemic agent

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

Heterocyclic compounds from Zeneca for hypercholesterolemia

Gonal-F approved for marketing in U.S.

Cambridge NeuroScience awarded sixteenth SBIR grant

Roussel Uclaf develops estrogenic compounds

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS